Stockreport

BioCryst stock surges 6% premarket after winning $35 million CDC contract for flu therapy [MarketWatch]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF BioCryst stock surges 6% premarket after winning $35 million CDC contract for flu therapy BioCryst Pharmaceuticals Inc. shares BCRX, +5.27% surged more than 6% premar [Read more]